日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts

更正:在体外和体内NB异种移植模型中,抗ROR1 CAR NK细胞与N-803联合应用可有效靶向神经母细胞瘤

Chu, Yaya; Nayyar, Gaurav; Tian, Meijuan; Lee, Dean A; Ozkaynak, Mehmet F; Ayala-Cuesta, Jessica; Klose, Kayleigh; Foley, Keira; Mendelowitz, Alyssa S; Luo, Wen; Liao, Yanling; Ayello, Janet; Behbehani, Gregory K; Riddell, Stanley; Cripe, Timothy P; Cairo, Mitchell S

Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.

曲贝替定可降低髓系抵抗力,从而提高抗 PD-1 免疫疗法的疗效并延缓胶质瘤的恶性进展。

Nazzaro Matthew, Mardis Elaine R, Canella Alessandro, Bhinder Bhavneet, Elemento Olivier, Behbehani Gregory, Currier Mark, Glaspell Andrea, Lee Dean A, Cripe Timothy P, Rajappa Prajwal

Patient-centered long-term follow-up for gene therapies aligns with ethics and science

以患者为中心的基因疗法长期随访符合伦理和科学原则。

Chapman, Carolyn Riley; Cripe, Timothy P; Bateman-House, Alison S

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma

采用抗ROR1 CAR NK细胞和分泌IL-21的溶瘤病毒联合免疫疗法治疗神经母细胞瘤

Chu, Yaya; Tian, Meijuan; Saini, Uksha; Ayala-Cuesta, Jessica; Klose, Kayleigh; Mendelowitz, Alyssa S; Foley, Keira; Ozkaynak, Mehmet F; Luo, Wen; Cripe, Timothy P; Lee, Dean A; Cassady, Kevin A; Cairo, Mitchell S

Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager

VNX-101 是一种腺相关病毒,其免疫原性较低,且能有效长期表达 CD19 T 细胞衔接器。

Currier, Mark A; Reha, Allen; Hutzen, Brian; Wang, Pin-Yi; Chen, Chun-Yu; Glaspell, Andrea M; Paudel, Siddhi Nath; Venkataramany, Akila S; Das, Debashree; Hanlon, Danielle; Kaspar, Allan; Varma, Samit; Kaspar, Brian; Morales, Pablo; Ralph, Peter; Johnson, Tonny; Weiss, Tania L; Cripe, Timothy P

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.

IL-12转基因表达增强可改善溶瘤病毒免疫疗法

Kim Yeaseul, Saini Uksha, Kim Doyeon, Hernandez-Aguirre Ilse, Hedberg Jack, Martin Alexia, Mo Xiaokui, Cripe Timothy P, Markert James, Cassady Kevin A, Dhital Ravi

Reviving the lost art of meeting reports

重拾会议报告这门失传的艺术

Cripe, Timothy P

Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society

肉瘤研究进展:2023年结缔组织肿瘤学会年会亮点

Cripe, Timothy P; Roberts, Ryan D; Chandler, Dawn S; Setty, Bhuvana A; Chen, Sonja; Shenoy, Archana; Venkataramany, Akila S; Ringwalt, Emily M; Scharschmidt, Thomas; Utset-Ward, Thomas; Konieczkowski, David J; Grignol, Valerie P; Beane, Joel D; Ruff, Samantha M; Pollock, Raphael E

Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma

抗MCAM CAR修饰的扩增自然杀伤细胞与NKTR-255联合免疫疗法治疗神经母细胞瘤

Luo, Wen; Gardenswartz, Aliza; Hoang, Hai; Chu, Yaya; Tian, Meijuan; Liao, Yanling; Ayello, Janet; Rosenblum, Jeremy M; Mo, Xiaokui; Marcondes, A Mario; Overwijk, Willem W; Cripe, Timothy P; Lee, Dean A; Cairo, Mitchell S

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma.

在骨肉瘤模型中,曲贝替定可促进溶瘤病毒的抗肿瘤功效、病毒基因表达和免疫效应功能

Ringwalt Emily M, Currier Mark A, Glaspell Andrea M, Chen Chun-Yu, Cannon Matthew V, Cam Maren, Gross Amy C, Gust Matthew, Wang Pin-Yi, Boon Louis, Biederman Laura E, Schwarz Emily, Rajappa Prajwal, Lee Dean A, Mardis Elaine R, Carson William E, Roberts Ryan D, Cripe Timothy P